本文關(guān)鍵詞： 射頻消融 頸部淋巴結(jié)轉(zhuǎn)移癌 療效　出處：《中國超聲醫(yī)學(xué)雜志》2017年05期 　論文類型：期刊論文

【摘要】：目的評價超聲引導(dǎo)下射頻消融(RFA)治療頸部淋巴結(jié)轉(zhuǎn)移癌的療效及安全性。方法超聲引導(dǎo)下射頻消融治療49例惡性腫瘤術(shù)后發(fā)生頸部淋巴結(jié)轉(zhuǎn)移癌患者。結(jié)果總射頻轉(zhuǎn)移淋巴結(jié)病灶118枚,術(shù)后超聲造影示所有射頻病灶消融完全。并發(fā)癥主要有皮膚灼傷、局部疼痛、惡心、胃部不適等。平均隨訪(10.8±6.4)個月,均未發(fā)生局部復(fù)發(fā)和(或)腫瘤殘留。術(shù)后射頻灶均出現(xiàn)不同程度的縮小,射頻淋巴結(jié)明顯縮小(縮小率≥80%)65枚,部分縮小(50%≤縮小率80%)30枚,小部分縮小(縮小率50%)23枚。結(jié)論超聲引導(dǎo)下射頻消融技術(shù)可以作為頸部淋巴結(jié)轉(zhuǎn)移癌的微創(chuàng)治療手段,可提高治療療效及生存質(zhì)量。
[Abstract]:Objective to evaluate the efficacy and safety of radiofrequency ablation (RFA) guided by ultrasound in the treatment of metastatic cervical lymph node cancer. 118 frequently metastatic lymph node lesions, All radiofrequency lesions were ablated completely. The main complications were skin burns, local pain, nausea, stomach discomfort, etc. The average follow-up was 10.8 鹵6.4 months. There was no local recurrence and / or tumor residue. After operation, the radiofrequency foci were reduced to different degrees, and the radiofrequency lymph nodes were significantly reduced (the reduction rate 鈮，

本文編號：1545190